semaglutide and mounjaro vs Ozempic Expert Endocrinologist Explains the Difference Wegovy vs Mounjaro: Which weight-loss

Clinical trials show that approximately 44% of patients using semaglutide experience nausea, along with other gastrointestinal symptoms

GLP-1R mRNA and GLP-1 immunoreactivity was detected in the VTA and NAc, as well as other reward associated areas including lateral hypothalamus, lateral habenula, hippocampus, and substantia nigra (Merchenthaler et al., 1999)

Ready to learn if GLP-1 therapy is right for you

Lipodystrophy refers to an abnormal distribution and storage of fat cells, often leading to visceral obesity

On average, tirzepatide led to 20.2% weight loss compared to 13.7% with semaglutide over 72 weeks of treatment

Specially formulated by experts to enhance skin radiance, strengthen hair, and promote nail health